Artículos del autor

solaci

Other

The Higher the LDL-C Level, the Greater the Benefit in Mortality with Aggressive Therapy

The latest studies seem to support higher baseline LDL-C levels would justify further intensifying and already aggressive...
solaci -
Institutional News

See the Scientific Program of the Guatemala Sessions 2018

SOLACI returns to Guatemala after a decade, in order to continue boosting the development of interventional cardiovascular...
solaci -
Institutional News

All you need to know about Guatemala Sessions 2018

After over ten years, SOLACI returns to the country that hosted the first Regional Sessions: Guatemala. After such...
solaci -
Chronic Ischemic cardiopathy

Hybrid Revascularization or Conventional Surgery: History Is Still Being Written

Hybrid revascularization seems to achieve results similar to those of conventional myocardial revascularization surgery at 5 years, although...
solaci -
Structural heart disease

Baseline Pulmonary Hypertension Should Not Preclude TAVR

Pulmonary hypertension (PH) in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR) should not...
solaci -
Institutional News

Guatemala Sessions: Contest for Young Interventionists

Sponsored by Abbott Vascular LATAM 35th SOLACI Regional Sessions – 13° Central America and the Caribbean Regional Meeting June 1st and...
solaci -
Structural heart disease

Liver Failure as a Challenge for TAVR

Although surgical risk scores do not include liver failure (LF), patients who suffer from it and undergo...
solaci -
Structural heart disease

TAVR with Prior MRS: A New Challenge

The benefits of transcatheter aortic valve replacement (TAVR) for high-risk, prohibitive-risk (class I) or intermediate-risk (class IIa) patients have...
solaci -